Follow us on social media for our latest updates. The Belgian National Lottery visits our labs 02/04/2021 The Belgian National Lottery funds ProjectMinE, an international research consortium working on ALS genetics. To learn more, they paid a visit to our labs to speak to Philip Van Damme. Check the interview (in Dutch) in the video below, or visit ProjectMinE's website for more info. ProjectMinE Odysseus grant for Lynette Lim 31/03/2021 Lynette Lim was one of 13 top researchers to receive an Odysseus grant: funding and a university appointment for excellent researchers to establish an independent research group in Flanders. Renzo Mancuso awarded the David Hague Early Career Investigator of the Year 23/03/2021 Congratulations to Renzo Mancuso! He shares the 2021 David Hague Early Career Investigator of the Year Award, presented each year to the most outstanding early career researcher in the field of biomedical dementia research. Augustine Therapeutics, a VIB spin off, strengthens Board of Directors and sets up Scientific Advisory Board 19/03/2021 The reinforcement of Augustine Therapeutics’ boards is another important step in strengthening the company to further the development of new medicines treating multiple neurodegenerative diseases with high unmet need. Reversing ALS cellular symptoms in a patient-derived cell model 15/03/2021 A team of researchers led by Philip Van Damme and Ludo Van Den Bosch (VIB-KU Leuven Center for Brain & Disease Research) used stem cells derived from ALS-patients to study the role of TDP-43 mutations in the disease process. Why does spicy food make you feel hot? New explainer by Frone Vandewiele 08/02/2021 In a new video by Technopolis, Frone Vandewiele, PhD student in the Voets lab, imparts some practical TRP-based advice. One million euros for neurological research into rare diseases 25/01/2021 Prof. Dr. Pierre Vanderhaeghen has been awarded the Generet Prize for Rare Diseases for his research into the development of the human brain and ways in which things sometimes go wrong. This prestigious Prize, awarded by the Generet Fund which is managed by the King Baudouin Foundation, is linked to funding with a value of one million euros. Targeting Tau to keep neurons connected 19/01/2021 An international team of researchers led by Patrik Verstreken at VIB-KU Leuven has succeeded in reversing the effects of Tau, a protein implicated in over 20 different diseases, including Alzheimer’s disease. Behind the primer: Interview with Liesbeth Minnoye 14/01/2021 Dominique Morneau, chief editor of Nature Reviews Methods Primers, interviewed Liesbeth Minnoye about her experience writing a collaborative paper on chromatin accessibility profiling methods. Genetics reveals the link between blood insulin and gender: one size doesn’t fit all 11/01/2021 Researchers from the University of Surrey, VIB-KU Leuven, University of Lille, and a number of other institutions examined DNA variations in 151,188 Europeans without diabetes, to determine whether genetic differences can explain the known gender differences in how well the body is able to manage blood sugar and insulin levels. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next ›
The Belgian National Lottery visits our labs 02/04/2021 The Belgian National Lottery funds ProjectMinE, an international research consortium working on ALS genetics. To learn more, they paid a visit to our labs to speak to Philip Van Damme. Check the interview (in Dutch) in the video below, or visit ProjectMinE's website for more info. ProjectMinE
Odysseus grant for Lynette Lim 31/03/2021 Lynette Lim was one of 13 top researchers to receive an Odysseus grant: funding and a university appointment for excellent researchers to establish an independent research group in Flanders.
Renzo Mancuso awarded the David Hague Early Career Investigator of the Year 23/03/2021 Congratulations to Renzo Mancuso! He shares the 2021 David Hague Early Career Investigator of the Year Award, presented each year to the most outstanding early career researcher in the field of biomedical dementia research.
Augustine Therapeutics, a VIB spin off, strengthens Board of Directors and sets up Scientific Advisory Board 19/03/2021 The reinforcement of Augustine Therapeutics’ boards is another important step in strengthening the company to further the development of new medicines treating multiple neurodegenerative diseases with high unmet need.
Reversing ALS cellular symptoms in a patient-derived cell model 15/03/2021 A team of researchers led by Philip Van Damme and Ludo Van Den Bosch (VIB-KU Leuven Center for Brain & Disease Research) used stem cells derived from ALS-patients to study the role of TDP-43 mutations in the disease process.
Why does spicy food make you feel hot? New explainer by Frone Vandewiele 08/02/2021 In a new video by Technopolis, Frone Vandewiele, PhD student in the Voets lab, imparts some practical TRP-based advice.
One million euros for neurological research into rare diseases 25/01/2021 Prof. Dr. Pierre Vanderhaeghen has been awarded the Generet Prize for Rare Diseases for his research into the development of the human brain and ways in which things sometimes go wrong. This prestigious Prize, awarded by the Generet Fund which is managed by the King Baudouin Foundation, is linked to funding with a value of one million euros.
Targeting Tau to keep neurons connected 19/01/2021 An international team of researchers led by Patrik Verstreken at VIB-KU Leuven has succeeded in reversing the effects of Tau, a protein implicated in over 20 different diseases, including Alzheimer’s disease.
Behind the primer: Interview with Liesbeth Minnoye 14/01/2021 Dominique Morneau, chief editor of Nature Reviews Methods Primers, interviewed Liesbeth Minnoye about her experience writing a collaborative paper on chromatin accessibility profiling methods.
Genetics reveals the link between blood insulin and gender: one size doesn’t fit all 11/01/2021 Researchers from the University of Surrey, VIB-KU Leuven, University of Lille, and a number of other institutions examined DNA variations in 151,188 Europeans without diabetes, to determine whether genetic differences can explain the known gender differences in how well the body is able to manage blood sugar and insulin levels.
